| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |